Simplified Treatment of Anti-retrovirus in China (C-STAR)
To observe the efficacy and safety of simplified therapy regimen for treating with HIV-1 infected patients in Chinese real word.
| Condition(s) | HIV/AIDS |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | To observe the efficacy and safety of simplified therapy regimen for treating with HIV-1 infected patients in Chinese real word. |
| Who can participate | Inclusion Criteria: 1. HIV-1 infection confirmed 2. Agree to use simplified therapy regimen. 3. Agree to detect CD4 count at least once per half a year Exclusion Criteria: 1. Have participated in HIV vaccine clinical trial or other drug trials in the past three months. 2. Patients who could not complete the scheduled follow-up (such as weakness and poor compliance). 3. Patients who have the history of resistance or allergy to LPV/r or 3TC. |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | Guangzhou 8th People's Hospital |
| Locations | Guangzhou, Guangdong, China |
| Start date | 2017-11-01 |
| NCT ID | NCT03603977 |
| Official listing | https://clinicaltrials.gov/study/NCT03603977 |